Yiling Pharmaceutical's Subsidiary's Exclusive Product Qifang Bitong Tablets Included in National Reimbursement Drug List for First Time

Deep News12-07

On the evening of December 7, Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced that Qifang Bitong Tablets, an exclusive product of its wholly-owned subsidiary Beijing Yiling Pharmaceutical Co., Ltd., has been successfully included in the National Reimbursement Drug List (NRDL) for basic medical insurance, maternity insurance, and work-related injury insurance (2025 edition) through medical insurance negotiations. This marks the first inclusion of this product in the NRDL.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128170178?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-07 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128170178","market":"other","top_or_hot":-1,"title":"Yiling Pharmaceutical's Subsidiary's Exclusive Product Qifang Bitong Tablets Included in National Reimbursement Drug List for First Time","media":"Deep News","content":"<p>On the evening of December 7, Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced that Qifang Bitong Tablets, an exclusive product of its wholly-owned subsidiary Beijing Yiling Pharmaceutical Co., Ltd., has been successfully included in the National Reimbursement Drug List (NRDL) for basic medical insurance, maternity insurance, and work-related injury insurance (2025 edition) through medical insurance negotiations. This marks the first inclusion of this product in the NRDL.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yiling Pharmaceutical's Subsidiary's Exclusive Product Qifang Bitong Tablets Included in National Reimbursement Drug List for First Time</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYiling Pharmaceutical's Subsidiary's Exclusive Product Qifang Bitong Tablets Included in National Reimbursement Drug List for First Time\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-12-07 23:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On the evening of December 7, Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced that Qifang Bitong Tablets, an exclusive product of its wholly-owned subsidiary Beijing Yiling Pharmaceutical Co., Ltd., has been successfully included in the National Reimbursement Drug List (NRDL) for basic medical insurance, maternity insurance, and work-related injury insurance (2025 edition) through medical insurance negotiations. This marks the first inclusion of this product in the NRDL.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002603","symbol_name":"以岭药业","start_time":0,"source_url":"","article_id":"1128170178","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128170178","pubTimestamp":1765119854,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On the evening of December 7, Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced that Qifang Bitong Tablets, an exclusive product of its wholly-owned subsidiary Beijing Yiling Pharmaceutical Co.,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"002603":"以岭药业","BK0239":"医药制造","BK0042":"基因检测","BK0188":"融资融券","BK0046":"生物疫苗","BK0097":"医药电商"},"translate_title":"以岭药业子公司独家产品七方痹痛片首次纳入国家报销药品目录","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002603":1},"content_text":"On the evening of December 7, Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced that Qifang Bitong Tablets, an exclusive product of its wholly-owned subsidiary Beijing Yiling Pharmaceutical Co., Ltd., has been successfully included in the National Reimbursement Drug List (NRDL) for basic medical insurance, maternity insurance, and work-related injury insurance (2025 edition) through medical insurance negotiations. This marks the first inclusion of this product in the NRDL.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128170178","isCrawlerRequest":true}